MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is among the ten most frequent and deadly cancers, without effective therapies for most patients. More recently, drugs targeting deregulated growth factor signaling receptors have been developed, such as HGF-MET targeted therapy. We assessed MET and HGF gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Abboud, H.S., Camuzi, D., Rapozo, D.C., Fernandes, P.V., Nicolau-Neto, P., Guaraldi, S., Simão, T.A., Ribeiro Pinto, L.F., Gonzaga, I.M., Soares-Lima, S.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148886/
https://www.ncbi.nlm.nih.gov/pubmed/34037097
http://dx.doi.org/10.1590/1414-431X2020e10877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148886/
https://www.ncbi.nlm.nih.gov/pubmed/34037097
http://dx.doi.org/10.1590/1414-431X2020e10877

Ejemplares similares